CLEVELAND, Sept. 10, 2024 /PRNewswire/ — Axuall, the leader in clinical workforce intelligence, proudly announces that the United States Patent and Trademark Office has issued its Patent, No. 12,079,891, for “Systems and Methods for Verifying and Managing Digital Credentials.” As Axuall’s first patent, it also covers methods and systems for defining configurable collections associated with digital credentials, among several vital functions.
Used by leading U.S. healthcare, telehealth, and staffing organizations, Axuall’s provider data network and digital credential wallet optimize how healthcare credentials are acquired from primary sources, tracked, updated, and managed. The technology and process reduce information delays for healthcare organizations needing to verify and onboard clinicians safely and quickly to meet patient demand while improving provider satisfaction and reducing costly administrative burdens.
“At Axuall, we are dedicated to advancing the field of digital credential verification,” said Charlie Lougheed, CEO of Axuall and coinventor of the patent. “This patent represents a significant milestone in our mission to provide secure, efficient, and reliable credential management solutions. We are excited to continue leading the way with our partners in digital credential innovation.”
Digital credentials provide portability and convenience while reducing administrative costs. Connecting healthcare organizations and their providers directly to a network of certified primary source issuers ensures the authenticity and origin of credentials for verifications such as education, licenses, certification, training, organization affiliation, work history, and procedural experience.
About Axuall
Built with leading healthcare systems, Axuall is a workforce intelligence company powered by a national real-time practitioner data network. The technology enables healthcare systems, staffing firms, telehealth, and health plans to dramatically reduce onboarding and enrollment time while providing robust data insights for network planning, analytics, and reporting. To learn more, visit www.axuall.com or follow Axuall on LinkedIn.
Media Contact:
Jeff Rusack
axuall@knbcomm.com
SOURCE Axuall
Young Women Activists Launch "What Girls Want," Demand World Leaders Put Girls at the Center…
As a leader in neuroscience, Teva is committed to researching new treatment innovations that may…
As a leader in neuroscience, Teva remains committed to helping address unmet needs in the…
Sarclisa approved in the US as the first anti-CD38 therapy in combination with standard-of-care treatment…
MIAMI, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (OTC: SMFL) (“Smart for…
SAN FRANCISCO, Sept. 20, 2024 /PRNewswire/ -- The Global Ultrasound Institute (GUSI) is proud to…